Palasis Maria 4
4 · Lyra Therapeutics, Inc. · Filed Mar 20, 2024
Insider Transaction Report
Form 4
Palasis Maria
DirectorPresident & CEO
Transactions
- Award
Stock Option
2024-03-18+500,000→ 500,000 totalExercise: $5.77Exp: 2034-03-17→ Common Stock (500,000 underlying)
Footnotes (1)
- [F1]This option vests and becomes exercisable in 48 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following January 31, 2024.